Literature DB >> 16005177

Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders.

Ovsanna T Leyfer1, Joshua L Ruberg, Janet Woodruff-Borden.   

Abstract

The Beck Anxiety Inventory (BAI) and the Anxiety Disorders Interview Schedule (ADIS-IV) were administered to 193 adults at a major Midwestern university recruited from an anxiety research and treatment center. The BAI and its four factor scores were compared from individuals with a primary diagnosis of generalized anxiety disorder (GAD), specific or social phobia, panic disorder with or without agoraphobia, obsessive-compulsive disorder (OCD), and no psychiatric diagnosis. The cut scores on the BAI and its factors, their sensitivity, specificity, as well as positive and negative predictive values were calculated for each group. The results of this study support previous findings that the strongest quality of the BAI is its ability to assess panic symptomatology. The present study also expands on this notion by establishing that the BAI can be used as an efficient screening tool for distinguishing between individuals with and without panic disorder.

Entities:  

Mesh:

Year:  2005        PMID: 16005177     DOI: 10.1016/j.janxdis.2005.05.004

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  59 in total

1.  A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.

Authors:  Winston W Chung; Clara A Chen; L Adrienne Cupples; J Scott Roberts; Susan C Hiraki; Anil K Nair; Robert C Green; Robert A Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

2.  Unseen scars: Cocaine patients with prior trauma evidence heightened resting state functional connectivity (RSFC) between the amygdala and limbic-striatal regions.

Authors:  Michael J Gawrysiak; Kanchana Jagannathan; Paul Regier; Jesse J Suh; Kyle Kampman; Timothy Vickery; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2017-09-20       Impact factor: 4.492

3.  Psychiatric Symptom Improvement in Women Following Group Substance Abuse Treatment: Results from the Women's Recovery Group Study.

Authors:  R Kathryn McHugh; Shelly F Greenfield
Journal:  J Cogn Psychother       Date:  2010-04-01

4.  GRM8 genotype is associated with externalizing disorders and greater inter-trial variability in brain activation during a response inhibition task.

Authors:  Lance O Bauer; Jonathan M Covault
Journal:  Clin Neurophysiol       Date:  2020-04-02       Impact factor: 3.708

Review 5.  Key Components of Pain Management for Children and Adults with Sickle Cell Disease.

Authors:  Amanda M Brandow; Michael R DeBaun
Journal:  Hematol Oncol Clin North Am       Date:  2018-06       Impact factor: 3.722

6.  A genetically informative analysis of the association between dyadic adjustment, depressive symptoms, and anxiety symptoms.

Authors:  Mark A Whisman; Alta du Pont; Soo Hyun Rhee; Erica L Spotts; Paul Lichtenstein; Jody M Ganiban; David Reiss; Jenae M Neiderhiser
Journal:  J Affect Disord       Date:  2018-04-25       Impact factor: 4.839

Review 7.  Psychological Characteristics of Chronic Pain: a Review of Current Evidence and Assessment Tools to Enhance Treatment.

Authors:  Rhondene M Miller; Ronald S Kaiser
Journal:  Curr Pain Headache Rep       Date:  2018-03-14

8.  Postpartum Outcomes and Formal Mindfulness Practice in Mindfulness-Based Cognitive Therapy for Perinatal Women.

Authors:  Christina M Luberto; Elyse R Park; Janice H Goodman
Journal:  Mindfulness (N Y)       Date:  2017-10-06

9.  Mental health and risk of secondary medical complications in adults with pediatric-onset spinal cord injury.

Authors:  Alicia M January; Kathy Zebracki; Kathleen M Chlan; Lawrence C Vogel
Journal:  Top Spinal Cord Inj Rehabil       Date:  2014

10.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.